You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

12 Results
Guidelines and Advice
Status: Archived
ID: CED 20
Mar 2011
Guidelines and Advice
Status: Archived
ID: 1-20
Version: 2
Oct 2011
Guidelines and Advice
Status: Archived
ID: CED 23
Oct 2011
Guidelines and Advice
Status: Archived
ID: 1-12
Sep 2011
Guidelines and Advice
Status: Archived
ID: 2-18
Jun 2011
Guidelines and Advice
Status: Archived
ID: 2-22
Sep 2011
Guidelines and Advice
Status: Archived
ID: 21-3-3
Jan 2011
Guidelines and Advice
Status: Archived
ID: 8-4
Sep 2011
Guidelines and Advice
Status: Archived
ID: 1-15 Version 3
Version: 3
Sep 2011
Drug
Other Name(s): Lonsurf®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Nov 2024
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
teclistamab (Compassionate)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2024
Regimen
Cancer Type:
Gastrointestinal, 
Colorectal, 
Small bowel and appendix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    trifluridine / tipiracil - In combination with bevacizumab for treatment of metastatic colorectal cancer, according to clinical criteria
New Drug Funding Program
    Bevacizumab (Biosimilar) - In Combination with Trifluridine and Tipiracil for Previously Treated Metastatic Colorectal Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
trifluridine / tipiracil,
bevacizumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2024